Response Biomedical Corp.  

(Public, TSE:RBM)   Watch this stock  
Find more results for RBM
1.12
0.00 (0.00%)
Oct 23 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.76 - 2.00
Open     -
Vol / Avg. 0.00/6,846.00
Mkt cap 8.90M
P/E     -
Div/yield     -
EPS -0.11
Shares 7.95M
Beta -3.72
Inst. own     -
Nov 10, 2014
Q3 2014 Response Biomedical Corp Earnings Release (Estimated) Add to calendar
Aug 11, 2014
Q2 2014 Response Biomedical Corp Earnings Call
Aug 11, 2014
Q2 2014 Response Biomedical Corp Earnings Release
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 9.36% -52.02%
Operating margin -16.57% -27.79%
EBITD margin - -19.18%
Return on average assets 8.07% -42.01%
Return on average equity - -
Employees 65 -
CDP Score - -

Address

1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
Canada
+1-604-4566010 (Phone)
+1-604-4566066 (Fax)

Website links

Description

Response Biomedical Corporation (Response) develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical and environmental applications. RAMP represents a paradigm in diagnostics that provides sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The RAMP system is a platform technology that combines a sensitive, portable fluorescence detection system with simple lateral flow immunoassays. RAMP maintains key positive attributes of lateral flow immunoassays - simplicity, specificity, reliability and rapid results - but includes a method to overcome the performance limitations of early generation immunoassays that suffer from relatively poor sensitivity and precision.

Officers and directors

William J. Adams Chief Financial Officer, Corporate Secretary
Age: 51
Barbara Kinnaird Ph.D. Chief Operating Officer
Age: 46
Zheng Wang General Manager, Asia Pacific
Lewis J. Shuster Chairman of the Board
Anthony F. Holler M.D. Interim Chief Executive Officer, Director
Age: 61
Peter A. Thompson M.D. Director
Jonathan Wang Ph.D. Director
Age: 45
Joseph D. Keegan Ph.D. Independent Director
Clinton H. Severson Independent Director
Age: 66
David G. Wang MD, PhD Independent Director
Age: 51